A chemical screen in diverse breast cancer cell lines reveals genetic enhancers and suppressors of sensitivity to PI3K isoform-selective inhibition
Neil E. Torbett(Cancer Research Institute), David Stokoe(Enzo Life Sciences (United States)), Andrew Houk(Cancer Research Institute), Mark M. Moasser(University of California, San Francisco), William A. Weiss(City College of San Francisco), Kevan M. Shokat(Howard Hughes Medical Institute), Antonio Luna-Moran(Cancer Research Institute), Zachary A. Knight(Howard Hughes Medical Institute)
Cited by 125
Related Papers
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
|Nature|2013|2.5k
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
|Nature|2010|1.8k
Molecular Determinants of the Response of Glioblastomas to EGFR Kinase Inhibitors
|New England Journal of Medicine|2005|1.4k
IRE1 Signaling Affects Cell Fate During the Unfolded Protein Response
|Science|2007|1.4k